At the 2025 NSF Pharma Biotech Conference, a Q&A session delved into enhancing contamination control strategies (CCS) and fostering a sustainable quality culture within the pharmaceutical and biotechnology sectors. Key takeaways included the importance of a strong quality culture in influencing regulatory inspection outcomes, the need for advanced technologies and training to combat contamination risks, and the challenges of attracting and retaining skilled quality professionals. The panel emphasized continuous coaching, simplifying procedures, and encouraging early reporting of issues as crucial for improving operational resilience and reducing costs associated with poor quality.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://manufacturingchemist.com/nsf-pharma-biotech-conference-q-a-highlights-priorities-for
